Announcing CCSA’s Partnership with Children’s Oncology Group

CCS Associates, Inc. (CCSA) is pleased to announce their collaboration with Children Oncology Group (COG) in support of clinical and translational research in infants, children, and adolescent patient populations. COG, a National Cancer Institute (NCI) supported clinical trials group, is the world’s largest organization devoted exclusively to pediatric cancer research. To kick-off this collaboration, CCSA is excited to provide support in trial monitoring of COG-sponsored investigational research in pediatric patients with relapsed/refractory acute myeloid leukemia (R/R-AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. To learn more about this study, please refer to the link.

For further information regarding COG’s research program, please refer to the following link:

Little girl with paint on hands and face